Metraipolis › archive › dc_7b474dbac587

Evinacumab Treatment of Homozygous Familial Hypercholesterolemia Patients in a Real-World Setting: An Overview After the First Year of Therapy — Europe PMC PMID:42491512

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42491512
DOI: 10.1016/j.aed.2026.03.004
License (as archived): solo-consultazione
Archived: 2026-11-03T21:47:44.906Z
SHA-256 of the archived text: 6ac0ba9684c7e9566363dc260b2ddf71434fe70d13f1bf3f5b60ee5f6eebf324
Stable URL of this page: https://metraipolis.com/documento/dc_7b474dbac587

How to cite

Evinacumab Treatment of Homozygous Familial Hypercholesterolemia Patients in a Real-World Setting: An Overview After the First Year of Therapy — Europe PMC PMID:42491512 — Europe PMC (en), https://europepmc.org/article/MED/42491512 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7b474dbac587 (Metraipolis archive dc_7b474dbac587, sha256 6ac0ba9684c7e9566363dc260b2ddf71434fe70d13f1bf3f5b60ee5f6eebf324)

BibTeX

@misc{dc7b474dbac587,
  title = {Evinacumab Treatment of Homozygous Familial Hypercholesterolemia Patients in a Real-World Setting: An Overview After the First Year of Therapy — Europe PMC PMID:42491512},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42491512},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7b474dbac587; sha256 6ac0ba9684c7e9566363dc260b2ddf71434fe70d13f1bf3f5b60ee5f6eebf324},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42491512. Agents can read the archived copy with the MCP tool read_document.